Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Revista Colombiana de Nefrología
On-line version ISSN 2500-5006
Abstract
FLORES, Diana Ramírez et al. Serum procalcitonin as a marker of renal allograft function in the immediate post-transplant period. Rev. colom. nefrol. [online]. 2022, vol.9, n.2, 202. Epub Aug 01, 2022. ISSN 2500-5006. https://doi.org/10.22265/acnef.9.2.570.
Background
Procalcitonin (PCT) could be useful for evaluation of the renal allograft (RG) in the immediate post-transplant since its levels increase after elevation of the inflammatory cytokines (IL-6, TNF-β) during events of renal failure.
Purpose
Our objective was to determine the association of serum PCT with the function of the RG in the immediate post-transplant.
Methodology
A retrospective cohort from September 2018- April 2019 in the National Western Medical Center of the Mexican Social Security Institute (IMSS), was performed. Sixty-two recipients of living donor (LD) and deceased donor (DD) renal transplant (RT) with PCT evaluation before the seventh days of RT were included; and, events of early renal allograft failure (EAF) were recorded and compared to patients no EAF (nEAF).
Results
The recipients with EAF presented with higher PCT levels (13.90, 3.90, 1.22 ng/mL) compared to the nEAF group (0.32, 0.31, and 0.22 ng/ml) on days 1, 3, and 5, respectively (p < 0.05).
Conclusions
The PCT is a biological marker associated with EAF in the immediate post-transplant.
Keywords : Early renal allograft failure; Procalcitonin; Renal Transplant..